Clinical Trials Browser

Phase 3 × Fumigant 93 × 90 days × Clear all

NCT07623798 2026-06-03

A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003

Phase 3 Not yet recruiting

Multiple Myeloma, Recurrence

NCT02504489 2026-05-19

DUBLIN-3

Phase 3 Completed

559 enrolled 32 charts

Carcinoma, Non-Small-Cell Lung